Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 2024466
PUBLISHER: IMARC | PRODUCT CODE: 2024466
Genitourinary Drugs Market Report by Indication, Product, and Region 2026-2034
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global genitourinary drugs market size reached USD 34.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 40.2 Billion by 2034, exhibiting a growth rate (CAGR) of 1.68% during 2026-2034.
The genitourinary system includes kidneys, ureters, bladder, urethra, and genital organs, which play a vital role in reproduction and getting rid of waste products from the body. Its functioning can be hampered on account of congenital abnormalities, iatrogenic injuries, cancer, trauma, infections, hydronephrosis, and inflammation. Due to the rising number of individuals suffering from these diseases, there is a rise in the demand for genitourinary drugs across the globe. Genitourinary drugs help treat the reproductive organs, excretory system, and urinary tract conditions. They are also used in the treatment of bladder spasms and erectile dysfunction and suppressing uterine contractions to prevent preterm labor.
GENITOURINARY DRUGS MARKET TRENDS:
The increasing risk of genitourinary organ damage represents one of the major factors influencing the growth of the market. Moreover, as genitourinary drugs are effective in treating the pediatric population with chronic kidney failure and urinary tract infections, their sales are increasing around the world. Apart from this, the leading market players are focusing on advancing formulation techniques to introduce drugs that help treat chronic prostate cancer patients who have developed resistance to conventional chemotherapeutic and hormone therapy agents. Furthermore, several multinational companies (MNCs) are collaborating with biopharmaceutical leaders to launch next-generation therapeutics and strengthen their position in the market. This, in confluence with a considerable rise in the number of pipeline drugs in late-stage clinical trials, is contributing to the market growth. Besides this, the increasing funding for research and development (R&D) projects, along with improvements in the healthcare infrastructure sponsored by governing and non-governing agencies of numerous countries, is anticipated to drive the demand for genitourinary drugs in the coming years.
KEY MARKET SEGMENTATION:
Breakup by Indication:
- Prostate Cancer
- Ovarian Cancer
- Bladder Cancer
- Cervical Cancer
- Renal Cancer
- Erectile Dysfunction
- Urinary Tract Infections
- Urinary Incontinence and Overactive Bladder
- Sexually Transmitted Diseases
- Interstitial Cystitis
- Hematuria
- Benign Prostatic Hyperplasia
Breakup by Product:
- Urological
- Hormonal Therapy
- Gynecological
- Anti-infectives
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan plc (AbbVie Inc.), Antares Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Genentech Inc. (Roche Holding AG), GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.
KEY QUESTIONS ANSWERED IN THIS REPORT
1. How big is the global genitourinary drugs market?
2. What is the expected growth rate of the global genitourinary drugs market during 2026-2034?
3. What are the key factors driving the global genitourinary drugs market?
4. What has been the impact of COVID-19 on the global genitourinary drugs market?
5. What is the breakup of the global genitourinary drugs market based on the indication?
6. What is the breakup of the global genitourinary drugs market based on the product?
7. What are the key regions in the global genitourinary drugs market?
8. Who are the key players/companies in the global genitourinary drugs market?
Product Code: SR112026A4727
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Genitourinary Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Indication
- 6.1 Prostate Cancer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Ovarian Cancer
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Bladder Cancer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Cervical Cancer
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Renal Cancer
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Erectile Dysfunction
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Urinary Tract Infections
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Urinary Incontinence and Overactive Bladder
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
- 6.9 Sexually Transmitted Diseases
- 6.9.1 Market Trends
- 6.9.2 Market Forecast
- 6.10 Interstitial Cystitis
- 6.10.1 Market Trends
- 6.10.2 Market Forecast
- 6.11 Hematuria
- 6.11.1 Market Trends
- 6.11.2 Market Forecast
- 6.12 Benign Prostatic Hyperplasia
- 6.12.1 Market Trends
- 6.12.2 Market Forecast
7 Market Breakup by Product
- 7.1 Urological
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Hormonal Therapy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Gynecological
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Anti-infectives
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Allergan plc (AbbVie Inc.)
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 SWOT Analysis
- 13.3.2 Antares Pharma Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.3 AstraZeneca plc
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.4 Bayer AG
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Bristol-Myers Squibb Company
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.5.4 SWOT Analysis
- 13.3.6 Genentech Inc. (Roche Holding AG)
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 SWOT Analysis
- 13.3.7 GlaxoSmithKline plc
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Merck & Co. Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Novartis AG
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.9.4 SWOT Analysis
- 13.3.10 Pfizer Inc.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 Teva Pharmaceutical Industries Ltd.
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.1 Allergan plc (AbbVie Inc.)
Product Code: SR112026A4727
List of Figures
- Figure 1: Global: Genitourinary Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Genitourinary Drugs Market: Sales Value (in Billion USD), 2020-2025
- Figure 3: Global: Genitourinary Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
- Figure 4: Global: Genitourinary Drugs Market: Breakup by Indication (in %), 2025
- Figure 5: Global: Genitourinary Drugs Market: Breakup by Product (in %), 2025
- Figure 6: Global: Genitourinary Drugs Market: Breakup by Region (in %), 2025
- Figure 7: Global: Genitourinary Drugs (Prostate Cancer) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 8: Global: Genitourinary Drugs (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 9: Global: Genitourinary Drugs (Ovarian Cancer) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 10: Global: Genitourinary Drugs (Ovarian Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 11: Global: Genitourinary Drugs (Bladder Cancer) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 12: Global: Genitourinary Drugs (Bladder Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 13: Global: Genitourinary Drugs (Cervical Cancer) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 14: Global: Genitourinary Drugs (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 15: Global: Genitourinary Drugs (Renal Cancer) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 16: Global: Genitourinary Drugs (Renal Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 17: Global: Genitourinary Drugs (Erectile Dysfunction) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 18: Global: Genitourinary Drugs (Erectile Dysfunction) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 19: Global: Genitourinary Drugs (Urinary Tract Infections) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 20: Global: Genitourinary Drugs (Urinary Tract Infections) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 21: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 22: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 23: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 24: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 25: Global: Genitourinary Drugs (Interstitial Cystitis) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 26: Global: Genitourinary Drugs (Interstitial Cystitis) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 27: Global: Genitourinary Drugs (Hematuria) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 28: Global: Genitourinary Drugs (Hematuria) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 29: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 30: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 31: Global: Genitourinary Drugs (Urological) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 32: Global: Genitourinary Drugs (Urological) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 33: Global: Genitourinary Drugs (Hormonal Therapy) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 34: Global: Genitourinary Drugs (Hormonal Therapy) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 35: Global: Genitourinary Drugs (Gynecological) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 36: Global: Genitourinary Drugs (Gynecological) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 37: Global: Genitourinary Drugs (Anti-infectives) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 38: Global: Genitourinary Drugs (Anti-infectives) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 39: Global: Genitourinary Drugs (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 40: Global: Genitourinary Drugs (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 41: North America: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 42: North America: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 43: United States: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 44: United States: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 45: Canada: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 46: Canada: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 47: Asia-Pacific: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 48: Asia-Pacific: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 49: China: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 50: China: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 51: Japan: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 52: Japan: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 53: India: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 54: India: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 55: South Korea: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 56: South Korea: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 57: Australia: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 58: Australia: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 59: Indonesia: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 60: Indonesia: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 61: Others: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 62: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 63: Europe: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 64: Europe: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 65: Germany: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 66: Germany: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 67: France: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 68: France: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 69: United Kingdom: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 70: United Kingdom: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 71: Italy: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 72: Italy: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 73: Spain: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 74: Spain: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 75: Russia: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 76: Russia: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 77: Others: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 78: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 79: Latin America: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 80: Latin America: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 81: Brazil: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 82: Brazil: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 83: Mexico: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 84: Mexico: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 85: Others: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 86: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 87: Middle East and Africa: Genitourinary Drugs Market: Sales Value (in Million USD), 2020 & 2025
- Figure 88: Middle East and Africa: Genitourinary Drugs Market: Breakup by Country (in %), 2025
- Figure 89: Middle East and Africa: Genitourinary Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 90: Global: Genitourinary Drugs Industry: SWOT Analysis
- Figure 91: Global: Genitourinary Drugs Industry: Value Chain Analysis
- Figure 92: Global: Genitourinary Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Genitourinary Drugs Market: Key Industry Highlights, 2025 and 2034
- Table 2: Global: Genitourinary Drugs Market Forecast: Breakup by Indication (in Million USD), 2026-2034
- Table 3: Global: Genitourinary Drugs Market Forecast: Breakup by Product (in Million USD), 2026-2034
- Table 4: Global: Genitourinary Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
- Table 5: Global: Genitourinary Drugs Market: Competitive Structure
- Table 6: Global: Genitourinary Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.